SAFER Wearables Study

  • Research type

    Research Study

  • Full title

    A study of the acceptability and performance of wearables for atrial fibrillation screening in older adults

  • IRAS ID

    283812

  • Contact name

    Peter H Charlton

  • Contact email

    pc657@medschl.cam.ac.uk

  • Sponsor organisation

    University of Cambridge

  • Duration of Study in the UK

    2 years, 1 months, 31 days

  • Research summary

    Atrial fibrillation (AF) is an irregular heart rhythm which causes a five-fold increase in the risk of stroke. If AF is recognised then the risk of stroke can be reduced by taking tablets regularly. However, AF is not recognised in many people (approximately 425,000 in England), meaning that they live with an increased risk of stroke. Therefore, it is important to find ways to identify AF more reliably.

    Recently, wearable devices have been developed which could be useful for identifying AF. Several devices allow you to monitor your heart activity in daily life, including wristbands, smart watches and chest-patch monitors. The aim of this study is to assess the acceptability and performance of wearables for use in AF screening in elderly subjects.

    We (researchers at the University of Cambridge) will invite selected people from the East of England who have previously participated in the SAFER Programme to participate in this study. We will invite 130 SAFER participants to also participate in this study: 65 without AF, and 65 with AF. Everyone who participates will be aged 65 or older.

    Participants will be asked to wear three devices for seven days: a wristband, a watch, and a chest patch. These devices will collect measurements of their heart’s activity. We will also ask participants to tell us how they found wearing the devices by completing a questionnaire. We will investigate how participants found wearing each device, and how accurately each device can be used to identify AF. The study will provide evidence to determine whether wearable devices could be useful for identifying AF in daily life.

    The study is funded by the British Heart Foundation.

  • REC name

    East Midlands - Leicester Central Research Ethics Committee

  • REC reference

    20/EM/0255

  • Date of REC Opinion

    19 Nov 2020

  • REC opinion

    Further Information Favourable Opinion